MN Services Vermogensbeheer’s United Therapeutics UTHR Stock Holding History

MN Services Vermogensbeheer’s Portfolio UTHR Stock Details UTHR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-21,300	Closed	-$4.68M	–	536
2023 Q4	$4.68M	Sell	21,300 -800	-4%	-$184K	0.04%	369
2023 Q3	$4.99M	Hold	22,100	–	–	0.05%	357
2023 Q2	$4.88M	Buy	+22,100	New	+$4.9M	0.05%	379
2019 Q2	–	Sell	-7,399	Closed	-$868K	–	661
2019 Q1	$868K	Hold	7,399	–	–	0.01%	611
2018 Q4	$705K	Buy	7,399 +600	+9%	+$69.6K	0.01%	603
2018 Q3	$869K	Hold	6,799	–	–	0.02%	636
2018 Q2	$769K	Hold	6,799	–	–	0.02%	649
2018 Q1	$764K	Sell	6,799 -400	-6%	-$50.8K	0.02%	642
2017 Q4	$887K	Sell	7,199 -100	-1%	-$12.7K	0.03%	603
2017 Q3	$855K	Hold	7,299	–	–	0.02%	624
2017 Q2	$947K	Buy	7,299 +6,171	+547%	+$770K	0.03%	614
2017 Q1	$143K	Hold	1,128	–	–	0.03%	564
2016 Q4	$153K	Hold	1,128	–	–	0.03%	551
2016 Q3	$133K	Hold	1,128	–	–	0.03%	572
2016 Q2	$108K	Hold	1,128	–	–	0.03%	580
2016 Q1	$110K	Buy	+1,128	New	+$143K	0.03%	612

Other funds holding UTHR

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

ACA

Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.89% 1-Year Est. Return

MN Services Vermogensbeheer's UTHR Position: Q1 2024 in Review

MN Services Vermogensbeheer sold out of United Therapeutics (UTHR) in Q1 2024, closing a stake of 21,300 shares — an estimated $4.68M sold.

MN Services Vermogensbeheer first reported a position in UTHR in Q1 2016 and held it in 16 quarters. The position peaked at $4.99M in Q3 2023. 526 funds tracked by Wall St. Rank hold UTHR as of Q1 2024.

MN Services Vermogensbeheer reported no remaining United Therapeutics position as of Q1 2024 after selling out during the quarter.
MN Services Vermogensbeheer sold 21,300 United Therapeutics shares in Q1 2024, an estimated $4.68M.
MN Services Vermogensbeheer first reported a position in United Therapeutics in Q1 2016 and held it in 16 quarters.
MN Services Vermogensbeheer's United Therapeutics position peaked at $4.99M in Q3 2023.
526 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2024.

Based on MN Services Vermogensbeheer's 13F filing for Q1 2024, filed 29 Apr 2024.